Volume 16; Issue 3

Main
Journal of Immunotherapy
Volume 16; Issue 3

Journal of Immunotherapy

Volume 16; Issue 3

1

CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)

Tahara, H., Zitvogel, L., Storkus, W. J., McKinney, T. G., Robbins, P. D., Lotze, M. T.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 127 KB

1994

2

LACK OF AN IMMUNOSUPPRESSIVE EFFECT OF INTER-LEUKIN-10 ON THE MURINE ANTI-TUMOR IMMUNE RESPONSE

Barth, R. J., Coppola, M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 67 KB

1994

3

POLYCLONALLY ACTIVATED CD8+ T CELLS FROM KAPOSIʼS SARCOMA PATIENTS PROPAGATED IN HOLLOW FIBER BIOREACTORS

Boyle, Larry, Feeney, Lee Ann, Vertin, Beth, Oshidari, Farshid, Talib, Sohel, Breslert, Herbert, Moody, Dewey J.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 124 KB

1994

4

ACTIVE IMMUNITY TO THE CARCINOEMBRYONIC ANTIGEN (CEA) IN PATIENTS TREATED WITH AN ANTI-IDIOTYPE MONOCLONAL ANTIBODY VACCINE

Foon, K. A., Chakraborty, M., John, W., Sherratt, A., Köhler, H., Chatterjee, M. Bhattacharya

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

5

INTERLEUKIN 12 AS IMMUNOADJUVANT

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

6

OIL-BASED DELIVERY OF IL-2, IL-4, IL-12, and IL-15

Rubin, J. T., Brumfield, A., Lotze, H. T.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

7

QUANTITATIVE PCR FOR EXPRESSION OF THE IL4 GENE IN BIOPSIES OF PATIENTS RECEIVING GENETICALLY-MODIFIED TUMOR VACCINE

Suminami, Y., Elder, E. M., Lotze, M. T., Whiteside, T. L.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 119 KB

1994

8

DISCORDANT BIOLOGIC EFFECTS OF VIRAL IL-10 AND AUTHENTIC IL-10 IN MURINE TUMOR MODELS

Suzuki, T., Tahara, H., Robbins, P. D., Lotze, M. T.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 128 KB

1994

9

LYMPHOCYTE RESPONSES TO B7 EXPRESSING HUMAN CANCER CELL LINES

Dessurcault, S., Gallinger, S.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 100 KB

1994

10

BNHANCEMENT OF THE PLATELET-MEDIATED CYTOTOXICITY BY IL-2 AND PLATELET-ACTIVATING FACTOR (PAF)

Kiselevsky, M. V., Tuguz, A. R., Cherepovsky, D. N., Buntsevich, A. M., Bykovskaya, S. W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 100 KB

1994

11

Hyperthermia Enhances the Cytotoxicity of National Institutes of Health 3T3 Cells Transfected with a Noncleavable Transmembrane Pro-Tumor Necrosis Factor Deletion Mutant

Tomasovic, Stephen P., Khodadadian, Mojgan, Hung, Mien-Chie, Klostergaard, Jim

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 655 KB

1994

12

Phase II Trials of High-Dose Interleukin-2 and Lymphokine-Activated Killer Cells in Advanced Breast Carcinoma and Carcinoma of the Lung, Ovary, and Pancreas and Other Tumors

Sparano, Joseph A., Fisher, Richard I., Weiss, Geoffrey R., Margolin, Kim, Aronson, Frederick R., Hawkins, Michael J., Atkins, Michael B., Dutcher, Janice P., Gaynor, Ellen R., Boldt, David H., Dorosh

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 717 KB

1994

13

CYTOTOXIC ACTIVITY BY PEPTIDE-INDUCED CD4+ T-LYMPHOCYTES AGAINST TUMOR CELLS EXPRESSING POINT-MUTATED Ki-RAS

Abrams, S., Wells, D., Kantor, J., Schlom, J.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 67 KB

1994

14

MECHANISMS OF INTERACTION BETWEEN TUMOR IRRADIATION AND IL-2 THERAPY

Hillman, G. G., Younes, E., Dezso, B., Ali, E., Maughan, R. L., Kukuruga, M., Montecillo, E., Pontes, J. Edson, Haas, G. P.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 115 KB

1994

15

DIFFERENCES BETWEEN ONCOLYTIC NEWCASTLE DISEASE VIRUS (NDV) STRAINS

Horwath, J., Horak, A., Sinkowics, J G

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

16

CYTOLYTIC AND NON-CYTOLYTIC T-CELL LINES AGAINST COLORECTAL CARCINOMA

JACOB, L., Somasundaram, R., Monos, D., Peritt, D., Mastrangelo, M., Hart, E., Herlyn, D.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

17

ANTI-ANGIOGENIC ACTIVITY OF INTERFERON WHEN ADMINISTERED INTRA-ARTERIALLY IN COMBINATION WITH CHEMOTHERAPY DRUGS

Medenica, R. D., Mukerjee, S., Holland, W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 128 KB

1994

18

ROLE OF INTERLEUKIN-2 IN THE ANTITUMOR ACTIVITY OF A RECOMBINANT CARCINOEMBRYONIC ANTIGEN-VACCINIA VIRUS (rV-CEA) VACCINE

McLaughlin, J. P., Kantor, J. A., Schlom, J., Greiner, I. W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 128 KB

1994

19

ANALYSIS OF SENSITIVITY OF ACTIVATED CD8+ T CELLS USED FOR THE TREATMENT OF KAPOSIʼS SARCOMA TO CD3-INDUCED APOPTOSIS

Moody, Dewey J.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 128 KB

1994

20

IMPROVED TUMOR TARGETING OF A GENETICALLY ENGINEERED SINGLE-CHAIN Fv (sFv) OF THE PANCARCINOMA MONOCLONAL ANTIBODY (MAb) CC49 WHEN GIVEN IN COMBINATION WITH INTERFERON-GAMMA (IFY-γ)

Nieroda, C., Milenic, D., Schlom, J., Greiner, J. W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 113 KB

1994

21

Response in Patients with Metastatic Renal Cell Carcinoma (RCC) during the Treatment with Alpha Interferon in Combination with 5-Fluorouracil

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 119 KB

1994

22

RADIOIMMUNOTHERAPY OF NON-HODGKINʼS LYMPHOMA WITH AN ANTI-CD22 MONOCLONAL ANTIBODY

Sharkey, R. M., Juweid, M., Behr, T., Mattes, J., Goldenberg, D. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 119 KB

1994

23

CLINICAL RESPONSES OF PRIMARY HUMAH CNS TUMORS TO OKT3/CYCYLOPHOSPHAMIDE

Wisemant, C., Hammock, V., Barto, N. L., Walluch, V.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 127 KB

1994

24

BNDOLYMPHATIC IMMUNOTHERAPY OF BLADDER CANCER PATIENTS BY LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT IL-2 (RIL-2)

Bykovskava, S. I., Malakhova, I. V., Figurin, I. K., Kiselevely, M. V.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 108 KB

1994

25

A RECOMBINANT F(ab') IMMUNOTOXIN CAUSES REGRESSION OF A PREVIOUSLY INCURABLE WITH IMMUNOTHERAPY HUMAN COLORECTAL CANCER XENOGRAFT

Debinski, W., Paston, I.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 100 KB

1994

26

PHASE I TRIAL OF BATIMASTAT (BB-94), A NOVEL MATRIX METALLOPROTEINASE INHIBITOR IN PATIENTS WITH ADVANCED CANCER

Wojtowicz, S., Ness, E., Dick, R., Low, J., Barter, J., McCann, P., Hawkins, M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 84 KB

1994

27

Influence of Biological Response Modifiers

Li, J., Merton, D. A., Thakur, M. L., Barr, J., Wilder, S., OʼHara, M. D., Gibbons, G., Goldberg, B.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 512 KB

1994

28

Potential to Involve Multiple Effector Cells with Human Recombinant Interleukin-2 and Antiganglioside Monoclonal Antibodies in a Canine Malignant Melanoma Immunotherapy Model

Helfand, Stuart C., Soergel, Steve A., Donner, Robin L., Gan, Jacek, Hank, Jacquelyn A., Lindstrom, Mary J., Sondel, Paul M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 916 KB

1994

29

Intraperitoneal Adoptive Immunotherapy of Ovarian Carcinoma with Tumor-Infiltrating Lymphocytes and Low-Dose Recombinant Interleukin-2

Freedman, Ralph S., Edwards, Creighton L., Kavanagh, John J., Kudelka, Andrzej P., Katz, Ruth L., Carrasco, Cesar H., Atkinson, Edward N., Scott, Wanza, Tomasovic, Barbara, Templin, Stacie, Platsoucas

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 1.11 MB

1994

30

Phase II Trial of Recombinant Interleukin-1β in Patients with Metastatic Renal Cell Carcinoma

Redman, Bruce G., Abubakr, Yousif, Chou, Ta-hsu, Esper, Peggy, Flaherty, Lawrence E.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 392 KB

1994

31

Phase II Trial of Recombinant Human Macrophage Colony-Stimulating Factor in Metastatic Soft Tissue Sarcoma

Momin, Feroze A., Zalupski, Mark, Heilbrun, Lance K., Flaherty, Lawrence, Fyfe, Gwen, Baker, Laurence H., Redman, Bruce G.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 378 KB

1994

32

Bilateral Adrenal Hemorrhage and Adrenal Insufficiency in a Patient with Lymphomatous Adrenal Infiltration Following Administration of a Fusion Toxin (DAB486 Interleukin-2)

Cohen, Roger, Jaffe, Elaine S., Stetler-Stevenson, Mary-Alice, Sausville, Edward A., DeNigris, Ellen C., Woodworth, Thasia, Foss, Francine M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 448 KB

1994

33

EXPERIMENTAL APPROACHES TO REDUCE DOSE-LIMITING RADIOANTIBODY-INDUCED MYELOTOXICITY

Blumenthal, R. D., Sharkey, R. M., Goldenberg, P. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 124 KB

1994

34

ONCONASE(ONC), A PROTEIN USED FOR THE THERAPY OF PATIENTS WITH ADVANCED PANCREATIC CANCER (PC)

Chun, H., Costanzi, J., Puccio, C., Panella, T., Coombe, N., Mikulski, S., Shogen, K., Meches, D., Mittelman, A.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 124 KB

1994

35

TARGETED GENE DELIVERY TO ACCOMPLISH GENE THERAPY FOR CANCER

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 124 KB

1994

36

ACTIVE SPECIFIC CHEMOIMMUNOTHERAPY OF RELPASED OR REFRACTORY BREAST AND GASTROINTESTINAL CANCER

Gold, J. E., Itzkowitz, S. H., Stevens, A., Reddish, M., Lonqenecker, B. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

37

IDEC-C2B8

Grillo-López, A. J., Maloney, D. G., Bodkin, D., Schilder, R. I., White, C., Foon, K., Janakiraman, N., Neidhart, J., Rosenberg, J., Shen, C. D., Royston, I., Levy, R.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

38

Functional Activity of a Recombinant Anti-Ganglioside GD2-IL2 Fusion Protein

Hank, J. A., Surfus, J., Gillies, S. D., Jaeger, P., Reisfeld, R. A., Sondel, F. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 115 KB

1994

39

LYSIS OF HUMAN TUMOR CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTI-GANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES

Helfand, S. C., Donner, R. L., Hank, J. A., Sondel, P. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 115 KB

1994

40

IL-4 CAN AUGMENT MELANOMA CELL IMMUNOGENICITY

Hoon, D. S.B., Uchiyama, A., Morton, D. L.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 115 KB

1994

41

PERI-OPERATIVE HUMORAL MODULATION BY POLYADENYLIC-POLYURIDYLIC ACID (PAPU) IN PATIENTS WITH BREAST CANCER

Khan, A. L., Richardson, S., Campbell, M., Drew, J., Larsen, F., Heys, S. D., Ah-See, A. K., Eremin, O.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

42

EFFECTS OF THE ADOPTIVE TRANSFER OF CELLS SECRETING GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH COLON CANCER

Kim, J. A., Martin, E. W., Aldrich, W., Heffelfinger, M., Triozzi, P. L.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

43

HIGH EFFICIENCY GENETIC MODIFICATION OF UNSTIMULATED PRIMARY CD8 AND CD34 CELLS USING ADENO-ASSOCIATED VIRUS PLASMID LIPOSOME COMPLEXES

Lebkowski, Jane S., Brunette, Elisa, Kilinski, Lydia, Murugesh, Deepa, Berson, Amy E., Philip, Mohan, Okarma, Thomas B., Philip, Ramila

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

44

IFN-GAMMA INDUCED APOPTOSIS IN ME 180 CERVICAL CARCINOMA CELLS IS THE RESULT OF STARVATION FOR THE ESSENTIAL AMINO-ACID L-TRYPTOPHAN

Konan, V., Taylor, M. W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

45

THYMIC PEPTIDE INDUCES APOPTOSIS IN UNDIFFERENTIATED T TUMOR CELLS

LIU, T., KETTERING, J. D.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

46

THE LEWIS Y CARBOHYDRATE ANTIGEN AS TARGET FOR SPECIFIC CANCER IMMUNOTHERAPY

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

47

VACCINATION OF RHESUS MONKEYS WITH AN ANTI-IDIOTYPE ANTIBODY MIMICKING LEWIS Y

Loibner, H., Janzek, E., Mayer, P., Liehl, E.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

48

A CTL CLONE SPECIFIC FOR THE METH A MURINE SARCOMA SUCCESSFULLY TREATS ESTABLISHED METASTATIC DISEASE

Mayordomo, I. I., Storkus, W. I., DeLeo, R., Lotze, M. T., DeLeo, A. B.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

49

INTRAVENOUS BRYOSTATIN-1 CAUSES IN VIVO ACTIVATION & EXPANSION OF MURINE SPLENOCYTES

McFadden, A., Kostuchenko, P., Burnes, K., Barrett, S., Turner, A., Grant, S., Bear, H. D.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 128 KB

1994

50

RETROVIRUS MEDIATED GENE TRANSFER OF THE HUMAN IL-2 GENE INTO HUMAN TUMOR CELLS GROWING IN TISSUE CULTURE

Nayak, S. K., Han, L., Dillman, R. O., Gangavalli, R.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 113 KB

1994

51

GROWTH OF HUMAN TUMOR INFILTRATING LYMPHOCYTES IN TISSUE CULTURE FOR USE IN ADOPTIVE CELLULAR IMMUNOTHERAPY

Nayak, S. K., Beutel, L., Irani, S., Dillman, R. O.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 113 KB

1994

52

EXPRESSION AND FUNCTION OF SIGNAL TRANSDUCING PROTEINS IN NK AND T CELLS IN PATIENTS WITH OVARIAN CARCINOMA

Rabinowich, H., Lai, P., Crowley-Nowick, P. A., Whiteside, T. L.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

53

FINAL RESULTS OF A RANDOMIZED CONTROLLED TRIAL (RCT) OF LONG TERM AUTOLYMPHOCYTE THERAPY (ALT) IN PATIENTS WITH METASTATIC RENAL CELL CANCER (mRCC)

Ross, S D, Miesowicz, F.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

54

PHASE IS STUDY OF MELIMMUNE (BIVALENT) ANTI-ID ANTIBODIES (Ab) IN PATIENTS WITH RESECTED MELANOMA

Saleh, M. N., Lalisan, D. Y., Gibson, M. G., Merritt, J., Crillo-Lopez, A., Lo Buglio, A. F.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 112 KB

1994

55

CUNICAL ACTIVITY IN AN EARLY PHASE I TRIAL OF PRIMATIZEDTM IDEC-CE9.1 - AN ANTI-CD4 MONOCLONAL ANTIBODY - IN RA

Solinger, A M, Yocum, D E, Tesser, J., Gluck, O., OʼSulivan, F., Henkel, C., Cornett, M., Lipani, J.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 119 KB

1994

56

A RANDOMIZED PHASE I TRIAL OF ETOPOSIDE (VP-16) AND GM-CSF FOR REFRACTORY SOLID CANCERS

Weiss, G R, Shaffer, D., Clark, G M, Rinaldi, D., Rodriguez, G I, Eckardt, J R, Stephens, S., VonHoff, D D

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 127 KB

1994

57

BIOLOGICAL AND CLINICAL EFFECTS OF POLY A

Witt, P. L., Zahir, S. A., McAuliffe, T. L., Ritch, P. S., Borden, B. C.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

58

Compositional and Functional Analysis of a Conditioned Medium Utilized in the Ex Vivo Polyclonal Activation of Human T Lymphocytes for Adoptive Immunotherapy

Zhang, J., Kurtzberg, L., Babbitt, B.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

59

A PHASE II STUDY OF riFN–β+/- cRA IN RECURRENT GLIOMAS

Yung, WKA, Levin, V A, Kyritsis, A, Jaeckle, K, Vaickus, L, Peterson, P

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

60

HIGH EFFICIENCY TRANSDUCTION OF THE IFN-CONSENSUS GENE INTO MAMMALIAN CELLS WITH AN AAV VECTOR

Zhang, J. F., Hu, C. J., Geng, Y. P., Taylor, M. W.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

61

B7.1 EXPRESSION ENHANCES EFFECTIVE IL-12 MEDIATED ANTITUMOR IMMUNITY

Zitvogel, L., Tahara, H., Robbins, P., Clark, M., Lotze, M. T.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 108 KB

1994

62

CULTURE OF DENDRITIC CELLS FROM MURINE BONE MARROW SUPPLEMENTED WITH GM-CSF AND TNF-ALPHA

Zorina, T., Mayordomo, I. I., Watkins, S., Lotze, M. T., DeLeo, A. B., Ildstad, S. T.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 108 KB

1994

63

NATURAL KILLER CELL ACTIVITY AS INDEPENDENT PROGNOSTIC INDICATOR OF SURVIVAL IN ADVANCED COLON CANCER PATIENTS

Crispen, R G, Simonich, W L, Williams, R M

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 108 KB

1994

64

NATURAL KILLER CELL ACTIVITY IS INDEPENDENT PROGNOSTIC FACTOR IN METASTATIC NON-SMALL CELL LUNG CANCER WITH GOOD PERFORMANCE STATUS

Crispen, R. G., Simonich, W. L., Williams, R. M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 100 KB

1994

65

PHASE 1 TRIAL OF ORALLY ADMINISTERED PENTOSAN POLYSULPHATE (PPS) IN PATIENTS WITH ADVANCED MALIGNANCIES

Marshall, JL, Wellstein, A, Al-Kawas, F, Andris, R, Hawkins, MJ

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 84 KB

1994

66

VITILIGO FOLLOWING IMMUNOTHERAPY WITH IFNα AND IL-2 IN MELANOMA PATIENTS - CLINICAL EVIDENCE FOR MELANOCYTE-LINEAGE SPECIFIC ANTIGENS AS TUMOR TARGET EPITOPES

Scheibenbogen, C., Keilholz, U., Hunstein, W., Klinik, V.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 84 KB

1994

67

Announcements

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 38 KB

1994

68

A SIMPLE GENERAL METHOD FOR OPSONIZATION OF HUMAN AUTOLOGOUS TUMOR VACCINES BY THE NATURAL ANTI-GAL ANTIBODY

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 122 KB

1994

69

AMPLIFICATION OF POLY A

Johnson, A. G., Mohrman, M., Ewel, C.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 118 KB

1994

70

PHASE I TRIAL OF ANTI-B4 BLOCKED RICIN (B4bR) GIVEN AS A 28 DAY CONTINUOUS INFUSION (CI)

Murray, J. L., McLaughlin, P. W., Rosenblum, M. G., Brewer, H., LeBherz, D., OʼBrien, S., Hagemeister, F. B., Esseltine, D., Keating, M.

Journal:

Journal of Immunotherapy

Year:

1994

File:

PDF, 113 KB

1994